Latest profit margin for Conformis: -72.73% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2023
Trailing 12 months ending Jun 2023
The latest profit margin for CFMS is -72.73% as of June 2023. That compares with -99.97% in the prior-year period — up 27.3% year over year. That is below the Healthcare sector average of 13.89%. Investors often review this figure alongside Conformis's historical trend and sector peers before judging valuation or financial health.
Over the past year, CFMS's profit margin moved from -99.97% to -72.73% — a 27.3% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Conformis's valuation or profitability profile.
Against Healthcare companies, CFMS currently prints -72.73% for profit margin, while the sector average sits near 13.89%. That is roughly 623.8% below the sector mean. Large gaps often invite a closer look at Conformis's growth, margins, and balance sheet.
Profit Margin shows how effectively Conformis converts resources into returns. At -72.73%, CFMS may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -99.97% in the prior-year period — up 27.3% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting CFMS's profit margin (-72.73%), review year-over-year change from -99.97%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.